Glycobiology Market To Witness Steep Growth At The Rate Of 13% From 2030
A new-fangled norm is likely to be observed by the healthcare vertical going forward. In other words, the novel healthcare vertical normal for supply chains, tech projects, governing critical supplies, regulations, and resilience would be new frameworks built by inter-governmental and governmental agencies for data sharing and response to disease. The Glycobiology Market is there to move along the private and public collaborations and alliances.
Extensive
research related to carbohydrate molecules in various fields such as marine
science and food & beverages is expected to fuel the growth of the
global glycobiology market over the period of 2020 to 2030. With most
stakeholders present in North America, the market in the region will hold sway
throughout the forecast period.
The
global glycobiology market is expected to expand at an impressive CAGR of
nearly 13% from 2020 to 2030, and reach a valuation of around US$ 3.5 Bn by the end of 2030, according to a new report by Persistence Market
Research (PMR).
Get
Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/4769
Company
Profiles:
·
Merck
KGaA
·
Bio-Techne
Corporation
·
Bruker
Corporation
·
Thermo
Fisher Scientific, Inc.
·
Shimadzu
Corporation
·
ProZyme
Inc.
·
NEB
Inc.
·
Agilent
Technologies
·
New
England Biolabs
·
Takara
Bio
·
Waters
Corporation
·
Danaher
Corporation
Request
for Methodology @ https://www.persistencemarketresearch.com/methodology/4769
Key
Takeaways from Glycobiology Market Study
·
On
the basis of product, the enzymes segment is expected to dominate the market
through the forecast period, and is anticipated to be the most lucrative
segment. Due to high adoption of enzymes to conduct various research
initiatives, this segment is expected to witness high incremental opportunity,
globally.
·
On
the basis of application, the drug discovery and development segment is
expected to dominate the market, and is anticipated to be the most lucrative
segment over the forecast period.
·
On
the basis of end user, the biopharmaceutical companies segment is expected to
account for the highest revenue share in the global glycobiology market, and is
expected to witness the fastest growth over the forecast period. Factors such
as increasing demand for novel drug development, especially for chronic
diseases such as cancer and diabetes, are expected to boost revenue share
contribution from biopharmaceutical companies. Research laboratories are also
expected to register significant growth during the forecast period.
·
North
America will lead the growth of the global glycobiology market through 2030, followed by the market in Europe.
“Due
to the COVID-19 pandemic, industrial and academic research related to
cancer and diabetes has slowed down, which will slow down the growth of
the glycobiology market to some extent in the near term,” says a PMR analyst.
Access
Full Report @ https://www.persistencemarketresearch.com/checkout/4769
Glycobiology Market:
Competition Landscape
Some
of the key market participants in the glycobiology market included in PMR’s
report include Merck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermo
Fisher Scientific, Inc., Shimadzu Corporation, Plexera Bioscience LLC, New
England Biolabs Inc., Agilent Technologies, Inc., and ProZyme, Inc.
What
Else is in the Report?
Persistence
Market Research offers a unique perspective and actionable insights on the
glycobiology market in its latest study, presenting historical demand
assessment of 2015–2019 and
projections for the years 2020–2030. Research of this report has been done based on
segmentation into product (instruments, enzymes, consumables, and reagent
kits), enzyme (galactosidases, glcnac transferases, and others), application
(drug discovery and development, diagnostic applications, industrial applications,
therapeutic applications, and others), and end user (biopharmaceutical
companies, research laboratories, hospitals, diagnostic centers, contract
research organizations, biotechnology industries, academic institutes, and
others), across seven key regions of the world.
About
Us:
Persistence
Market Research is here to provide companies a one-stop solution with regards
to bettering customer experience. It does engage in gathering appropriate
feedback after getting through personalized customer interactions for adding
value to customers’ experience by acting as the “missing” link between
“customer relationships” and “business outcomes’. The best possible returns are
assured therein.
Contact
Us:
Persistence
Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website –
https://www.persistencemarketresearch.com
Comments
Post a Comment